179 related articles for article (PubMed ID: 30455694)
1. Molecular Markers Distinguishing T Cell Subtypes With TSDR Strand-Bias Methylation.
Minskaia E; Saraiva BC; Soares MMV; Azevedo RI; Ribeiro RM; Kumar SD; Vieira AIS; Lacerda JF
Front Immunol; 2018; 9():2540. PubMed ID: 30455694
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
[TBL] [Abstract][Full Text] [Related]
3. Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells.
Polansky JK; Schreiber L; Thelemann C; Ludwig L; Krüger M; Baumgrass R; Cording S; Floess S; Hamann A; Huehn J
J Mol Med (Berl); 2010 Oct; 88(10):1029-40. PubMed ID: 20574810
[TBL] [Abstract][Full Text] [Related]
4. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
5. Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
Wang L; Liu Y; Han R; Beier UH; Thomas RM; Wells AD; Hancock WW
Mol Cell Biol; 2013 Oct; 33(20):4106-15. PubMed ID: 23979593
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms of regulation of Foxp3 expression.
Lal G; Bromberg JS
Blood; 2009 Oct; 114(18):3727-35. PubMed ID: 19641188
[TBL] [Abstract][Full Text] [Related]
7. Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections.
Ngalamika O; Liang G; Zhao M; Yu X; Yang Y; Yin H; Liu Y; Yung S; Chan TM; Lu Q
Immunol Invest; 2015; 44(2):126-36. PubMed ID: 25083793
[TBL] [Abstract][Full Text] [Related]
8. Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.
Kressler C; Gasparoni G; Nordström K; Hamo D; Salhab A; Dimitropoulos C; Tierling S; Reinke P; Volk HD; Walter J; Hamann A; Polansky JK
Front Immunol; 2020; 11():609891. PubMed ID: 33488615
[TBL] [Abstract][Full Text] [Related]
9. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
10. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation controls Foxp3 gene expression.
Polansky JK; Kretschmer K; Freyer J; Floess S; Garbe A; Baron U; Olek S; Hamann A; von Boehmer H; Huehn J
Eur J Immunol; 2008 Jun; 38(6):1654-63. PubMed ID: 18493985
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Tet2 is associated with Foxp3 TSDR hypermethylation in regulatory T cell of allergic rhinitis.
Tan L; Qiu T; Xiang R; Cao C; Deng Y; Tao Z; Xu Y
Life Sci; 2020 Jan; 241():117101. PubMed ID: 31778687
[TBL] [Abstract][Full Text] [Related]
13. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.
Baron U; Floess S; Wieczorek G; Baumann K; Grützkau A; Dong J; Thiel A; Boeld TJ; Hoffmann P; Edinger M; Türbachova I; Hamann A; Olek S; Huehn J
Eur J Immunol; 2007 Sep; 37(9):2378-89. PubMed ID: 17694575
[TBL] [Abstract][Full Text] [Related]
14. IFNγ+ Treg in-vivo and in-vitro represent both activated nTreg and peripherally induced aTreg and remain phenotypically stable in-vitro after removal of the stimulus.
Daniel V; Trojan K; Adamek M; Opelz G
BMC Immunol; 2015 Aug; 16():45. PubMed ID: 26268522
[TBL] [Abstract][Full Text] [Related]
15. FOXP3 promoter demethylation reveals the committed Treg population in humans.
Janson PC; Winerdal ME; Marits P; Thörn M; Ohlsson R; Winqvist O
PLoS One; 2008 Feb; 3(2):e1612. PubMed ID: 18286169
[TBL] [Abstract][Full Text] [Related]
16. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
17. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
[TBL] [Abstract][Full Text] [Related]
18. Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function.
Trojan K; Unterrainer C; Weimer R; Bulut N; Morath C; Aly M; Zhu L; Opelz G; Daniel V
PLoS One; 2017; 12(3):e0173773. PubMed ID: 28296931
[TBL] [Abstract][Full Text] [Related]
19. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
Front Immunol; 2018; 9():907. PubMed ID: 29774027
[TBL] [Abstract][Full Text] [Related]
20. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
